187 related articles for article (PubMed ID: 16622614)
1. Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature.
Girolami A; Tezza F; Scapin M; Vettore S; Casonato A
J Thromb Thrombolysis; 2006 Apr; 21(2):175-8. PubMed ID: 16622614
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand's disease: clinical management.
Federici AB; Castaman G; Thompson A; Berntorp E
Haemophilia; 2006 Jul; 12 Suppl 3():152-8. PubMed ID: 16684011
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
4. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease.
Makris M; Colvin B; Gupta V; Shields ML; Smith MP
Thromb Haemost; 2002 Sep; 88(3):387-8. PubMed ID: 12353065
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.
Federici AB; Castaman G; Franchini M; Morfini M; Zanon E; Coppola A; Tagliaferri A; Boeri E; Mazzucconi MG; Rossetti G; Mannucci PM
Haematologica; 2007 Jul; 92(7):944-51. PubMed ID: 17606445
[TBL] [Abstract][Full Text] [Related]
6. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
Johnstone IB; Crane S
Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
[TBL] [Abstract][Full Text] [Related]
7. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
Federici AB
Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and von Willebrand's disease (vWD).
Abshire TC
Thromb Res; 2006; 118 Suppl 1():S3-7. PubMed ID: 16580053
[TBL] [Abstract][Full Text] [Related]
9. The 80th anniversary of von Willebrand's disease: history, management and research.
Federici AB; Berntorp E; Lee CA
Haemophilia; 2006 Nov; 12(6):563-72. PubMed ID: 17083505
[TBL] [Abstract][Full Text] [Related]
10. [Desmopressin in hemophilia A and Von Willebrand's disease].
Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis.
Nichols TC; Bellinger DA; Tate DA; Reddick RL; Read MS; Koch GG; Brinkhous KM; Griggs TR
Arteriosclerosis; 1990; 10(3):449-61. PubMed ID: 2344301
[TBL] [Abstract][Full Text] [Related]
14. The factor VIII/von Willebrand factor complex: basic and clinical issues.
Federici AB
Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
[TBL] [Abstract][Full Text] [Related]
15. [Thromboembolism of the pulmonary artery in Willebrand's disease].
Galstian GM; Vasil'ev SA; Galuziak VS; Likhacheva EA; Pliushch OP; Rudakova VE; Riazanova IB; Sakhibov IaD; Togonidze DK; Khorobrykh LS
Ter Arkh; 2005; 77(12):33-9. PubMed ID: 16514817
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
Kurth AA; Ludwig G; Scharrer I
Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
18. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
19. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
20. Reduced prevalence of arterial thrombosis in von Willebrand disease.
Sanders YV; Eikenboom J; de Wee EM; van der Bom JG; Cnossen MH; Degenaar-Dujardin ME; Fijnvandraat K; Kamphuisen PW; Laros-van Gorkom BA; Meijer K; Mauser-Bunschoten EP; Leebeek FW;
J Thromb Haemost; 2013 May; 11(5):845-54. PubMed ID: 23506463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
